Sort   by:  
 Page size 
UnknownGWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.
Not available
S-EPMC5363591 | biostudies-literature
UnknownAssessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Not available
S-EPMC5568360 | biostudies-literature
UnknownConstitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.
Not available
S-EPMC5445615 | biostudies-literature
UnknownMental health and stress among ICU healthcare professionals in France according to intensity of the COVID-19 epidemic.
Not available
S-EPMC8177250 | biostudies-literature
UnknownImmediate Hypersensitivity to Contrast Agents: The French 5-year CIRTACI Study.
Not available
S-EPMC6537532 | biostudies-literature
UnknownIntravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
Not available
S-EPMC10600726 | biostudies-literature
UnknownEffect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC10326520 | biostudies-literature
UnknownSimvastatin in Critically Ill Patients with Covid-19.
Not available
S-EPMC10755839 | biostudies-literature
Sort   by:  
 Page size